[
  {
    "ts": "2026-02-23T02:23:49+00:00",
    "headline": "Barclays Takes Neutral Stance on Gilead Sciences (GILD) Despite Strategic Refocus",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 13 Best NASDAQ Dividend Stocks to Buy Now. On February 20, Barclays began coverage of Gilead Sciences, Inc. (NASDAQ:GILD) with an Equal Weight rating. The firm set a $155 price target on the stock. The firm said the company is returning its focus to what it has [‚Ä¶]",
    "url": "https://finance.yahoo.com/news/barclays-takes-neutral-stance-gilead-022349658.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "3958fca3-186b-37b8-b756-2311c4075b52",
      "content": {
        "id": "3958fca3-186b-37b8-b756-2311c4075b52",
        "contentType": "STORY",
        "title": "Barclays Takes Neutral Stance on Gilead Sciences (GILD) Despite Strategic Refocus",
        "description": "",
        "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 13 Best NASDAQ Dividend Stocks to Buy Now. On February 20, Barclays began coverage of Gilead Sciences, Inc. (NASDAQ:GILD) with an Equal Weight rating. The firm set a $155 price target on the stock. The firm said the company is returning its focus to what it has [‚Ä¶]",
        "pubDate": "2026-02-23T02:23:49Z",
        "displayTime": "2026-02-23T02:23:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Barclays Takes Neutral Stance on Gilead Sciences (GILD) Despite Strategic Refocus",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ha22PhpGlsEhK3tmOzGDVw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CkBvnQJGKRIUyIDAWZszGw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/barclays-takes-neutral-stance-gilead-022349658.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/barclays-takes-neutral-stance-gilead-022349658.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "BCS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T11:15:41+00:00",
    "headline": "Gilead to acquire Arcellx for $7.8 billion",
    "summary": "Feb 23 () - Gilead Sciences said ‚Äåon Monday it ‚Äåwill buy cancer therapy ‚Äãdeveloper Arcellx for an implied equity value of $7.8 ‚Äåbillion, ‚Å†sending shares of Arcellx climbing ‚Å†77.",
    "url": "https://finance.yahoo.com/news/gilead-acquire-arcellx-7-8-111541314.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "e7d81dc8-c589-3573-99c8-7a644ef8bca0",
      "content": {
        "id": "e7d81dc8-c589-3573-99c8-7a644ef8bca0",
        "contentType": "STORY",
        "title": "Gilead to acquire Arcellx for $7.8 billion",
        "description": "",
        "summary": "Feb 23 () - Gilead Sciences said ‚Äåon Monday it ‚Äåwill buy cancer therapy ‚Äãdeveloper Arcellx for an implied equity value of $7.8 ‚Äåbillion, ‚Å†sending shares of Arcellx climbing ‚Å†77.",
        "pubDate": "2026-02-23T11:15:41Z",
        "displayTime": "2026-02-23T11:15:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/4d1704d0b159fd01bb66e5955f523af9",
          "originalWidth": 800,
          "originalHeight": 489,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V8FcAZ2HZF4nFOT4yy2xaw--~B/aD00ODk7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/4d1704d0b159fd01bb66e5955f523af9.cf.webp",
              "width": 800,
              "height": 489,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VLfrg2QcYqhyDCV5I9n6zg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/4d1704d0b159fd01bb66e5955f523af9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-acquire-arcellx-7-8-111541314.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-acquire-arcellx-7-8-111541314.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "ACLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T11:01:00+00:00",
    "headline": "Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel",
    "summary": "FOSTER CITY, Calif. & REDWOOD CITY, Calif., February 23, 2026--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has entered into a definitive agreement to acquire Arcellx (Nasdaq: ACLX) for $115 per share in cash at closing and one contingent value right of $5 per share, which represents an implied equity value of $7.8 billion payable at closing. Arcellx is a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incur",
    "url": "https://finance.yahoo.com/news/gilead-sciences-acquire-arcellx-maximize-110100514.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "b63a1407-0fa9-31b6-b99c-6abe13bf4b4e",
      "content": {
        "id": "b63a1407-0fa9-31b6-b99c-6abe13bf4b4e",
        "contentType": "STORY",
        "title": "Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel",
        "description": "",
        "summary": "FOSTER CITY, Calif. & REDWOOD CITY, Calif., February 23, 2026--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has entered into a definitive agreement to acquire Arcellx (Nasdaq: ACLX) for $115 per share in cash at closing and one contingent value right of $5 per share, which represents an implied equity value of $7.8 billion payable at closing. Arcellx is a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incur",
        "pubDate": "2026-02-23T11:01:00Z",
        "displayTime": "2026-02-23T11:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/db916ee653d5bb61381083eaa5da9a52",
          "originalWidth": 1728,
          "originalHeight": 576,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5endfg_bxOmc33HQNN4A9Q--~B/aD01NzY7dz0xNzI4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/db916ee653d5bb61381083eaa5da9a52.cf.webp",
              "width": 1728,
              "height": 576,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6zLN6Ivo8K2g33MEQDLvTQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/db916ee653d5bb61381083eaa5da9a52.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-acquire-arcellx-maximize-110100514.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-acquire-arcellx-maximize-110100514.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T12:54:43+00:00",
    "headline": "Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion",
    "summary": "Feb 23 () - Gilead Sciences will pay as much as $7.8 billion to acquire its partner Arcellex in its largest deal since 2020, the ‚Äåbiopharma company said on Monday, as it looks to strengthen its lineup ‚Äåof cancer treatments.",
    "url": "https://finance.yahoo.com/news/gilead-acquire-cancer-therapy-developer-125443430.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "4cbbf07b-7065-359a-91b5-a7d4fab54146",
      "content": {
        "id": "4cbbf07b-7065-359a-91b5-a7d4fab54146",
        "contentType": "STORY",
        "title": "Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion",
        "description": "",
        "summary": "Feb 23 () - Gilead Sciences will pay as much as $7.8 billion to acquire its partner Arcellex in its largest deal since 2020, the ‚Äåbiopharma company said on Monday, as it looks to strengthen its lineup ‚Äåof cancer treatments.",
        "pubDate": "2026-02-23T12:54:43Z",
        "displayTime": "2026-02-23T12:54:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/f256a1a47d2fe1738b01fffb3fca569b",
          "originalWidth": 800,
          "originalHeight": 489,
          "caption": "Logos of Gilead at the company‚Äôs booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zcDGAHCZfOvSH97aMngn0g--~B/aD00ODk7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/f256a1a47d2fe1738b01fffb3fca569b.cf.webp",
              "width": 800,
              "height": 489,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NTySBsnqUWmGkE3J_FhtqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/f256a1a47d2fe1738b01fffb3fca569b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-acquire-cancer-therapy-developer-125443430.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-acquire-cancer-therapy-developer-125443430.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "ACLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T12:35:16+00:00",
    "headline": "Stocks Down Pre-Bell as Trump Raises Global Tariffs Following Supreme Court Ruling",
    "summary": "The benchmark US stock measures were tracking in the red before the opening bell Monday as President",
    "url": "https://finance.yahoo.com/news/stocks-down-pre-bell-trump-123516237.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "c72c4c07-0aa8-3182-af08-26f22d926db5",
      "content": {
        "id": "c72c4c07-0aa8-3182-af08-26f22d926db5",
        "contentType": "STORY",
        "title": "Stocks Down Pre-Bell as Trump Raises Global Tariffs Following Supreme Court Ruling",
        "description": "",
        "summary": "The benchmark US stock measures were tracking in the red before the opening bell Monday as President",
        "pubDate": "2026-02-23T12:35:16Z",
        "displayTime": "2026-02-23T12:35:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "wall street stock market flag new york trading equity - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QVMgErJdOR7IkzCjRHm3pQ--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dimQxOClk1isv1IKNf9JtA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stocks-down-pre-bell-trump-123516237.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stocks-down-pre-bell-trump-123516237.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T11:36:00+00:00",
    "headline": "Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion",
    "summary": "Gilead Sciences has agreed to buy the rest of development partner Arcellx in a deal that values the biotechnology company at about $7.8 billion at closing.",
    "url": "https://www.wsj.com/tech/biotech/gilead-sciences-to-buy-arcellx-in-deal-valued-at-7-8-billion-53d57e3a?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "00cc6205-8a93-30dd-993c-a13cc383aa2c",
      "content": {
        "id": "00cc6205-8a93-30dd-993c-a13cc383aa2c",
        "contentType": "STORY",
        "title": "Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion",
        "description": "",
        "summary": "Gilead Sciences has agreed to buy the rest of development partner Arcellx in a deal that values the biotechnology company at about $7.8 billion at closing.",
        "pubDate": "2026-02-23T11:36:00Z",
        "displayTime": "2026-02-23T11:36:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/00cc6205-8a93-30dd-993c-a13cc383aa2c/gilead-sciences-to-buy.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/94dafe9cc49c2e92186b7e8630400280",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uPkGk0hX1VNEmW9kJcQNgQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/94dafe9cc49c2e92186b7e8630400280.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5Qo1eXs8g.tTSvpsQSXIYQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/94dafe9cc49c2e92186b7e8630400280.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/tech/biotech/gilead-sciences-to-buy-arcellx-in-deal-valued-at-7-8-billion-53d57e3a?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T11:32:02+00:00",
    "headline": "Stocks to Watch Monday: Domino's Pizza, Eli Lilly, Merck, Gilead",
    "summary": "‚ÜóÔ∏è Merck (MRK): The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss. One will house its cancer drugs, including blockbuster Keytruda. Shares rose roughly 1.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-tariffs-02-23-2026/card/stocks-to-watch-monday-domino-s-pizza-dominion-energy-american-airlines-RT1RccoqGTzQdkbqaSL7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "cb781f9d-b9a5-3f5a-bfb4-b439b3b47382",
      "content": {
        "id": "cb781f9d-b9a5-3f5a-bfb4-b439b3b47382",
        "contentType": "STORY",
        "title": "Stocks to Watch Monday: Domino's Pizza, Eli Lilly, Merck, Gilead",
        "description": "",
        "summary": "‚ÜóÔ∏è Merck (MRK): The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss. One will house its cancer drugs, including blockbuster Keytruda. Shares rose roughly 1.",
        "pubDate": "2026-02-23T11:32:02Z",
        "displayTime": "2026-02-23T11:32:02Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/cb781f9d-b9a5-3f5a-bfb4-b439b3b47382/stocks-to-watch-monday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/6f2132c0e52008396d8b8cc39474d877",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KnlNOKh2C6QgkEmemrj6mg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/6f2132c0e52008396d8b8cc39474d877.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zhLP7itajp.wiPUq1vzKdA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/6f2132c0e52008396d8b8cc39474d877.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-tariffs-02-23-2026/card/stocks-to-watch-monday-domino-s-pizza-dominion-energy-american-airlines-RT1RccoqGTzQdkbqaSL7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "NOVO.B"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "DPZ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "AAL"
            },
            {
              "symbol": "DAL"
            },
            {
              "symbol": "UAL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T14:41:07+00:00",
    "headline": "Stocks to Watch Monday: Novo Nordisk, Merck, Domino's, Gilead",
    "summary": "üîé Merck (MRK): The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss. One will house its cancer drugs, including blockbuster Keytruda. ‚ÜòÔ∏è Novo Nordisk (NVO), (DK:NOVO.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-tariffs-02-23-2026/card/stocks-to-watch-monday-domino-s-pizza-dominion-energy-american-airlines-RT1RccoqGTzQdkbqaSL7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "cb781f9d-b9a5-3f5a-bfb4-b439b3b47382",
      "content": {
        "id": "cb781f9d-b9a5-3f5a-bfb4-b439b3b47382",
        "contentType": "STORY",
        "title": "Stocks to Watch Monday: Novo Nordisk, Merck, Domino's, Gilead",
        "description": "",
        "summary": "üîé Merck (MRK): The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss. One will house its cancer drugs, including blockbuster Keytruda. ‚ÜòÔ∏è Novo Nordisk (NVO), (DK:NOVO.",
        "pubDate": "2026-02-23T14:41:07Z",
        "displayTime": "2026-02-23T14:41:07Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/cb781f9d-b9a5-3f5a-bfb4-b439b3b47382/stocks-to-watch-monday-novo.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/6f2132c0e52008396d8b8cc39474d877",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KnlNOKh2C6QgkEmemrj6mg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/6f2132c0e52008396d8b8cc39474d877.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zhLP7itajp.wiPUq1vzKdA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/6f2132c0e52008396d8b8cc39474d877.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-tariffs-02-23-2026/card/stocks-to-watch-monday-domino-s-pizza-dominion-energy-american-airlines-RT1RccoqGTzQdkbqaSL7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "NOVO.B"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "DPZ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "FBIN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T14:32:59+00:00",
    "headline": "Alphabet, Nvidia upgraded: Wall Street's top analyst calls",
    "summary": "Alphabet, Nvidia upgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/alphabet-nvidia-upgraded-wall-streets-143259140.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "0e00ac9c-f9cc-351f-8baf-6ce097c7ba00",
      "content": {
        "id": "0e00ac9c-f9cc-351f-8baf-6ce097c7ba00",
        "contentType": "STORY",
        "title": "Alphabet, Nvidia upgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "Alphabet, Nvidia upgraded: Wall Street's top analyst calls",
        "pubDate": "2026-02-23T14:32:59Z",
        "displayTime": "2026-02-23T14:32:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/alphabet-nvidia-upgraded-wall-streets-143259140.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/alphabet-nvidia-upgraded-wall-streets-143259140.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "LIFE"
            },
            {
              "symbol": "VFC"
            },
            {
              "symbol": "MNDY"
            },
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "PPHC"
            },
            {
              "symbol": "GIS"
            },
            {
              "symbol": "HSIC"
            },
            {
              "symbol": "BOBS"
            },
            {
              "symbol": "DE"
            },
            {
              "symbol": "WDAY"
            },
            {
              "symbol": "DOCU"
            },
            {
              "symbol": "YSS"
            },
            {
              "symbol": "PICS"
            },
            {
              "symbol": "BLK"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "TNDM"
            },
            {
              "symbol": "GOOG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T14:08:41+00:00",
    "headline": "Gilead Sciences to Acquire Arcellx in $7.8 Billion Deal",
    "summary": "Gilead Sciences (GILD) on Monday agreed to acquire cancer therapy developer Arcellx (ACLX) in a deal",
    "url": "https://finance.yahoo.com/news/gilead-sciences-acquire-arcellx-7-140841859.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "fa802eb6-3221-3495-acb9-ff999800ec6e",
      "content": {
        "id": "fa802eb6-3221-3495-acb9-ff999800ec6e",
        "contentType": "STORY",
        "title": "Gilead Sciences to Acquire Arcellx in $7.8 Billion Deal",
        "description": "",
        "summary": "Gilead Sciences (GILD) on Monday agreed to acquire cancer therapy developer Arcellx (ACLX) in a deal",
        "pubDate": "2026-02-23T14:08:41Z",
        "displayTime": "2026-02-23T14:08:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/237762dc68b4357ae0276e98e6bd4f45",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "gilead - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TbiHvgfuS1MkWKSA_.ObVQ--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/237762dc68b4357ae0276e98e6bd4f45.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6tzbnQBUfaHrKCR693hcMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/237762dc68b4357ae0276e98e6bd4f45.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-acquire-arcellx-7-140841859.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-acquire-arcellx-7-140841859.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "ACLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T14:06:07+00:00",
    "headline": "Wall Street Digests Supreme Court Tariff Ruling, Driving Premarket Losses for US Equity Futures",
    "summary": "US equity futures were down ahead of Monday's opening bell as investors digested a Supreme Court dec",
    "url": "https://finance.yahoo.com/news/wall-street-digests-supreme-court-140607893.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "2bbdc635-de6e-357b-b142-8fbe8c3d2348",
      "content": {
        "id": "2bbdc635-de6e-357b-b142-8fbe8c3d2348",
        "contentType": "STORY",
        "title": "Wall Street Digests Supreme Court Tariff Ruling, Driving Premarket Losses for US Equity Futures",
        "description": "",
        "summary": "US equity futures were down ahead of Monday's opening bell as investors digested a Supreme Court dec",
        "pubDate": "2026-02-23T14:06:07Z",
        "displayTime": "2026-02-23T14:06:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-digests-supreme-court-140607893.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-digests-supreme-court-140607893.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "DPZ"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T13:50:31+00:00",
    "headline": "Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid Renewed Trade Doubts",
    "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.5%, and the actively t",
    "url": "https://finance.yahoo.com/news/exchange-traded-funds-equity-futures-135031238.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "1e63fe48-3008-356a-a8f9-8b5264e417cb",
      "content": {
        "id": "1e63fe48-3008-356a-a8f9-8b5264e417cb",
        "contentType": "STORY",
        "title": "Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid Renewed Trade Doubts",
        "description": "",
        "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.5%, and the actively t",
        "pubDate": "2026-02-23T13:50:31Z",
        "displayTime": "2026-02-23T13:50:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/exchange-traded-funds-equity-futures-135031238.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/exchange-traded-funds-equity-futures-135031238.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "VIS"
            },
            {
              "symbol": "IGM"
            },
            {
              "symbol": "NWG"
            },
            {
              "symbol": "VDC"
            },
            {
              "symbol": "XSD"
            },
            {
              "symbol": "IYJ"
            },
            {
              "symbol": "IPK"
            },
            {
              "symbol": "EXI"
            },
            {
              "symbol": "SOXX"
            },
            {
              "symbol": "IVV"
            },
            {
              "symbol": "XRT"
            },
            {
              "symbol": "IBB"
            },
            {
              "symbol": "DPZ"
            },
            {
              "symbol": "IGV"
            },
            {
              "symbol": "EEM"
            },
            {
              "symbol": "SLV"
            },
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "IYW"
            },
            {
              "symbol": "PMR"
            },
            {
              "symbol": "BITO"
            },
            {
              "symbol": "IYK"
            },
            {
              "symbol": "D"
            },
            {
              "symbol": "UNG"
            },
            {
              "symbol": "XLE"
            },
            {
              "symbol": "EETH"
            },
            {
              "symbol": "XLY"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "FAS"
            },
            {
              "symbol": "BETH"
            },
            {
              "symbol": "IWM"
            },
            {
              "symbol": "XLI"
            },
            {
              "symbol": "GLD"
            },
            {
              "symbol": "RTH"
            },
            {
              "symbol": "IYH"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "XLF"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "FBIN"
            },
            {
              "symbol": "XLP"
            },
            {
              "symbol": "IYE"
            },
            {
              "symbol": "USO"
            },
            {
              "symbol": "FAZ"
            },
            {
              "symbol": "XLK"
            },
            {
              "symbol": "QQQ"
            },
            {
              "symbol": "SPY"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T13:44:18+00:00",
    "headline": "Gilead Bets Big On New Drug With $7.8 Billion Deal As It Takes On J&J",
    "summary": "Gilead Sciences announced an agreement to acquire Arcellx for $115 in cash per share, a 79% premium to the biotech's Friday close.  Gilead will pay an additional $5 per share if sales of its top drug, anito-cell, total at least $6 billion through 2029, which implies strong competition for Johnson & Johnson.  ACLX stock vaulted higher in early Monday stock market action, while GILD dipped slightly.",
    "url": "https://www.investors.com/news/technology/gilead-sciences-anito-cel-arcellx-acquisition/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "f57525e3-6a37-3c5e-bc63-85b5f7fdaa11",
      "content": {
        "id": "f57525e3-6a37-3c5e-bc63-85b5f7fdaa11",
        "contentType": "STORY",
        "title": "Gilead Bets Big On New Drug With $7.8 Billion Deal As It Takes On J&J",
        "description": "",
        "summary": "Gilead Sciences announced an agreement to acquire Arcellx for $115 in cash per share, a 79% premium to the biotech's Friday close.  Gilead will pay an additional $5 per share if sales of its top drug, anito-cell, total at least $6 billion through 2029, which implies strong competition for Johnson & Johnson.  ACLX stock vaulted higher in early Monday stock market action, while GILD dipped slightly.",
        "pubDate": "2026-02-23T13:44:18Z",
        "displayTime": "2026-02-23T13:44:18Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f57525e3-6a37-3c5e-bc63-85b5f7fdaa11/gilead-bets-big-on-new-drug.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/220b994ba82b273562061a4d57daf68d",
          "originalWidth": 945,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3HS_v1sTXYEP8DTCYUYLJg--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/220b994ba82b273562061a4d57daf68d.cf.webp",
              "width": 945,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I5EJ4LrwA0DL6x_L77OdSA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/220b994ba82b273562061a4d57daf68d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/gilead-sciences-anito-cel-arcellx-acquisition/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "LGND"
            },
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T13:16:00+00:00",
    "headline": "Gilead pays $7.8bn to take full control of promising multiple myeloma therapy",
    "summary": "Gilead Sciences Inc (NASDAQ:GILD, XETRA:GIS) has agreed to buy Arcellx in a deal valuing the clinical-stage biotechnology company at $7.8 billion, converting an existing partnership into outright ownership of a CAR T-cell therapy that could be approved by US regulators before the end of this...",
    "url": "https://www.proactiveinvestors.com/companies/news/1087773/gilead-pays-7-8bn-to-take-full-control-of-promising-multiple-myeloma-therapy-1087773.html",
    "source": "Proactive",
    "provider": "yfinance",
    "raw": {
      "id": "66da0260-6aaa-3214-a1f5-f4d087f50bd2",
      "content": {
        "id": "66da0260-6aaa-3214-a1f5-f4d087f50bd2",
        "contentType": "STORY",
        "title": "Gilead pays $7.8bn to take full control of promising multiple myeloma therapy",
        "description": "",
        "summary": "Gilead Sciences Inc (NASDAQ:GILD, XETRA:GIS) has agreed to buy Arcellx in a deal valuing the clinical-stage biotechnology company at $7.8 billion, converting an existing partnership into outright ownership of a CAR T-cell therapy that could be approved by US regulators before the end of this...",
        "pubDate": "2026-02-23T13:16:00Z",
        "displayTime": "2026-02-23T13:16:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/proactive_us_504/489dee05b7cf2b0ea2d5e4d7566aaa9e",
          "originalWidth": 1080,
          "originalHeight": 720,
          "caption": "Gilead pays $7.8bn to take full control of promising multiple myeloma therapy",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MIg5seV2Vw346RCUURUozg--~B/aD03MjA7dz0xMDgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/proactive_us_504/489dee05b7cf2b0ea2d5e4d7566aaa9e.cf.webp",
              "width": 1080,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8jHwSs2d1BRBDD7DbH1p5A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/proactive_us_504/489dee05b7cf2b0ea2d5e4d7566aaa9e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Proactive",
          "url": "https://www.proactiveinvestors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.proactiveinvestors.com/companies/news/1087773/gilead-pays-7-8bn-to-take-full-control-of-promising-multiple-myeloma-therapy-1087773.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-pays-7-8bn-full-131600311.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "ACLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T12:42:00+00:00",
    "headline": "This Biotech Stock Is Surging 78%. Gilead Sciences Agrees to Buy It.",
    "summary": "Gilead Sciences will pay an 80% premium to Arcellx‚Äôs closing price Friday to acquire the cancer drug developer.",
    "url": "https://www.barrons.com/articles/gilead-arcellx-stock-biotech-deal-2c2a89b8?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "80c0ca85-6b51-3afb-b465-d2a3b6d30e74",
      "content": {
        "id": "80c0ca85-6b51-3afb-b465-d2a3b6d30e74",
        "contentType": "STORY",
        "title": "This Biotech Stock Is Surging 78%. Gilead Sciences Agrees to Buy It.",
        "description": "",
        "summary": "Gilead Sciences will pay an 80% premium to Arcellx‚Äôs closing price Friday to acquire the cancer drug developer.",
        "pubDate": "2026-02-23T12:42:00Z",
        "displayTime": "2026-02-23T12:42:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/80c0ca85-6b51-3afb-b465-d2a3b6d30e74/this-biotech-stock-is-surging.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/8f73b572271e3db9173ed9d584f7687c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k6z.U.ttCHvbZx4iWGhDAQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/8f73b572271e3db9173ed9d584f7687c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sr6RnqNu0MhbRwnsmIp82w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/8f73b572271e3db9173ed9d584f7687c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/gilead-arcellx-stock-biotech-deal-2c2a89b8?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "ACLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T07:49:00+00:00",
    "headline": "Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy",
    "summary": "The acquisition bolsters Gilead‚Äôs sputtering cell therapy business with a medication the company expects to become a ‚Äúfoundational treatment‚Äù for the blood cancer, its CEO said.",
    "url": "https://www.biopharmadive.com/news/gilead-arcellx-acquire-multiple-myeloma-cell-therapy-anito-cel/812798/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "d452e55d-7fe7-3eb1-b994-94f9de6deef2",
      "content": {
        "id": "d452e55d-7fe7-3eb1-b994-94f9de6deef2",
        "contentType": "STORY",
        "title": "Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy",
        "description": "",
        "summary": "The acquisition bolsters Gilead‚Äôs sputtering cell therapy business with a medication the company expects to become a ‚Äúfoundational treatment‚Äù for the blood cancer, its CEO said.",
        "pubDate": "2026-02-23T07:49:00Z",
        "displayTime": "2026-02-23T07:49:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/7bd263bcae7d0506fb80282303540fe7",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "BioPharma Dive, an Industry Dive publication",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/U3g5.ulK0vcCqcdyFlYvVw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/7bd263bcae7d0506fb80282303540fe7.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DH6ljKWVk5FO27mUzvHUcQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/7bd263bcae7d0506fb80282303540fe7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/gilead-arcellx-acquire-multiple-myeloma-cell-therapy-anito-cel/812798/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-buy-arcellx-7-8b-074900241.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "ACLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T14:07:00+00:00",
    "headline": "What's in Store for These 5 Medical Companies This Earnings Season?",
    "summary": "IRWD, RXRX, NVAX, VTRS and NTLA gear up for earnings as the Medical sector posts solid sales growth despite a slight profit dip so far.",
    "url": "https://finance.yahoo.com/news/whats-store-5-medical-companies-140700168.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "09a74d47-a925-34c0-b330-7c1d11c1f4cd",
      "content": {
        "id": "09a74d47-a925-34c0-b330-7c1d11c1f4cd",
        "contentType": "STORY",
        "title": "What's in Store for These 5 Medical Companies This Earnings Season?",
        "description": "",
        "summary": "IRWD, RXRX, NVAX, VTRS and NTLA gear up for earnings as the Medical sector posts solid sales growth despite a slight profit dip so far.",
        "pubDate": "2026-02-23T14:07:00Z",
        "displayTime": "2026-02-23T14:07:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rR6iZHXu8FRY2qc4ebuBNA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TXlDKOevAW4cJAnlMECSwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/whats-store-5-medical-companies-140700168.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/whats-store-5-medical-companies-140700168.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RXRX"
            },
            {
              "symbol": "IRWD"
            },
            {
              "symbol": "NTLA"
            },
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "VTRS"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T13:39:00+00:00",
    "headline": "This Biotech Jumped 78%. Gilead Sciences Is Buying It.",
    "summary": "Gilead Sciences will pay an 80% premium to Arcellx‚Äôs closing price Friday to acquire the cancer drug developer.",
    "url": "https://www.barrons.com/articles/gilead-arcellx-stock-biotech-deal-2c2a89b8?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "80c0ca85-6b51-3afb-b465-d2a3b6d30e74",
      "content": {
        "id": "80c0ca85-6b51-3afb-b465-d2a3b6d30e74",
        "contentType": "STORY",
        "title": "This Biotech Jumped 78%. Gilead Sciences Is Buying It.",
        "description": "",
        "summary": "Gilead Sciences will pay an 80% premium to Arcellx‚Äôs closing price Friday to acquire the cancer drug developer.",
        "pubDate": "2026-02-23T13:39:00Z",
        "displayTime": "2026-02-23T13:39:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/80c0ca85-6b51-3afb-b465-d2a3b6d30e74/this-biotech-jumped-78-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/8f73b572271e3db9173ed9d584f7687c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k6z.U.ttCHvbZx4iWGhDAQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/8f73b572271e3db9173ed9d584f7687c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sr6RnqNu0MhbRwnsmIp82w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/8f73b572271e3db9173ed9d584f7687c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/gilead-arcellx-stock-biotech-deal-2c2a89b8?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "ACLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T16:44:47+00:00",
    "headline": "Gilead acquires CAR-T specialist Arcellx for $7.8bn",
    "summary": "Gilead is now waiting upon the FDA‚Äôs approval of anito-cel, Arcellx‚Äôs lead candidate, slated for December 2026.",
    "url": "https://www.pharmaceutical-technology.com/news/gilead-acquires-car-t-specialist-arcellx-for-7-8bn/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "761937de-ee01-30ec-ae38-b9ec6093ee65",
      "content": {
        "id": "761937de-ee01-30ec-ae38-b9ec6093ee65",
        "contentType": "STORY",
        "title": "Gilead acquires CAR-T specialist Arcellx for $7.8bn",
        "description": "",
        "summary": "Gilead is now waiting upon the FDA‚Äôs approval of anito-cel, Arcellx‚Äôs lead candidate, slated for December 2026.",
        "pubDate": "2026-02-23T16:44:47Z",
        "displayTime": "2026-02-23T16:44:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/c5481639a30ca16c37e9a7e5fdac7816",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.9Y77Ze7Br7bCrIjCphhaw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/c5481639a30ca16c37e9a7e5fdac7816.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RHrZDUBEKsL2gxnBc6qWCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/c5481639a30ca16c37e9a7e5fdac7816.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/gilead-acquires-car-t-specialist-arcellx-for-7-8bn/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-acquires-car-t-specialist-164447977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "ACLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T16:16:00+00:00",
    "headline": "Top Midday Stories: Novo Obesity Drug Doesn't Meet Primary Endpoint, Stock Falls; Gilead to Acquire Arcellx for $7.8 Billion",
    "summary": "All three major US stock indexes were down in late-morning trading Monday, as investors weigh the co",
    "url": "https://finance.yahoo.com/news/top-midday-stories-novo-obesity-161600151.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "66575aac-2f77-37e7-b76f-213bb003012b",
      "content": {
        "id": "66575aac-2f77-37e7-b76f-213bb003012b",
        "contentType": "STORY",
        "title": "Top Midday Stories: Novo Obesity Drug Doesn't Meet Primary Endpoint, Stock Falls; Gilead to Acquire Arcellx for $7.8 Billion",
        "description": "",
        "summary": "All three major US stock indexes were down in late-morning trading Monday, as investors weigh the co",
        "pubDate": "2026-02-23T16:16:00Z",
        "displayTime": "2026-02-23T16:16:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-novo-obesity-161600151.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-novo-obesity-161600151.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T15:27:00+00:00",
    "headline": "This Biotech Stock Is Having Its Best Day Ever. Gilead Sciences Is Buying It.",
    "summary": "Gilead Sciences will pay an 80% premium to Arcellx‚Äôs closing price Friday to acquire the cancer drug developer.",
    "url": "https://www.barrons.com/articles/gilead-arcellx-stock-biotech-deal-2c2a89b8?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "80c0ca85-6b51-3afb-b465-d2a3b6d30e74",
      "content": {
        "id": "80c0ca85-6b51-3afb-b465-d2a3b6d30e74",
        "contentType": "STORY",
        "title": "This Biotech Stock Is Having Its Best Day Ever. Gilead Sciences Is Buying It.",
        "description": "",
        "summary": "Gilead Sciences will pay an 80% premium to Arcellx‚Äôs closing price Friday to acquire the cancer drug developer.",
        "pubDate": "2026-02-23T15:27:00Z",
        "displayTime": "2026-02-23T15:27:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/80c0ca85-6b51-3afb-b465-d2a3b6d30e74/this-biotech-stock-is-having.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/8f73b572271e3db9173ed9d584f7687c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k6z.U.ttCHvbZx4iWGhDAQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/8f73b572271e3db9173ed9d584f7687c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sr6RnqNu0MhbRwnsmIp82w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/8f73b572271e3db9173ed9d584f7687c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/gilead-arcellx-stock-biotech-deal-2c2a89b8?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "ACLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T14:41:07+00:00",
    "headline": "Stocks to Watch Monday: Merck, Novo Nordisk, Eli Lilly, Gilead",
    "summary": "üîé Merck (MRK): The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss. One will house its cancer drugs, including blockbuster Keytruda. ‚ÜòÔ∏è Novo Nordisk (NVO), (DK:NOVO.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-tariffs-02-23-2026/card/stocks-to-watch-monday-domino-s-pizza-dominion-energy-american-airlines-RT1RccoqGTzQdkbqaSL7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "cb781f9d-b9a5-3f5a-bfb4-b439b3b47382",
      "content": {
        "id": "cb781f9d-b9a5-3f5a-bfb4-b439b3b47382",
        "contentType": "STORY",
        "title": "Stocks to Watch Monday: Merck, Novo Nordisk, Eli Lilly, Gilead",
        "description": "",
        "summary": "üîé Merck (MRK): The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss. One will house its cancer drugs, including blockbuster Keytruda. ‚ÜòÔ∏è Novo Nordisk (NVO), (DK:NOVO.",
        "pubDate": "2026-02-23T14:41:07Z",
        "displayTime": "2026-02-23T14:41:07Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/cb781f9d-b9a5-3f5a-bfb4-b439b3b47382/stocks-to-watch-monday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-tariffs-02-23-2026/card/stocks-to-watch-monday-domino-s-pizza-dominion-energy-american-airlines-RT1RccoqGTzQdkbqaSL7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PSKY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "FBIN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T19:10:14+00:00",
    "headline": "Equities, Treasury Yields Fall Intraday as Markets Weigh New Trump Tariffs",
    "summary": "US benchmark equity indexes and Treasury yields fell intraday as investors assessed new tariffs anno",
    "url": "https://finance.yahoo.com/news/equities-treasury-yields-fall-intraday-191014456.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "a23e57d1-134e-333a-a02f-fc626ef2cec9",
      "content": {
        "id": "a23e57d1-134e-333a-a02f-fc626ef2cec9",
        "contentType": "STORY",
        "title": "Equities, Treasury Yields Fall Intraday as Markets Weigh New Trump Tariffs",
        "description": "",
        "summary": "US benchmark equity indexes and Treasury yields fell intraday as investors assessed new tariffs anno",
        "pubDate": "2026-02-23T19:10:14Z",
        "displayTime": "2026-02-23T19:10:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a",
          "originalWidth": 1024,
          "originalHeight": 768,
          "caption": "Stocks_Chart market equity trading wall street - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0eWqzzTTIs4ZCQG0VOzLjA--~B/aD03Njg7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a.cf.webp",
              "width": 1024,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/woUn3cfJYPXMhxA4_4CCeg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/equities-treasury-yields-fall-intraday-191014456.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/equities-treasury-yields-fall-intraday-191014456.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T18:50:31+00:00",
    "headline": "Stocks to Watch Monday: Merck, Netflix, Novo Nordisk, Eli Lilly",
    "summary": "‚ÜóÔ∏è Merck (MRK): The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss. One will house its cancer drugs, including blockbuster Keytruda. Shares edged higher 1% on a strong day for health-care stocks.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-tariffs-02-23-2026/card/stocks-to-watch-monday-domino-s-pizza-dominion-energy-american-airlines-RT1RccoqGTzQdkbqaSL7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "cb781f9d-b9a5-3f5a-bfb4-b439b3b47382",
      "content": {
        "id": "cb781f9d-b9a5-3f5a-bfb4-b439b3b47382",
        "contentType": "STORY",
        "title": "Stocks to Watch Monday: Merck, Netflix, Novo Nordisk, Eli Lilly",
        "description": "",
        "summary": "‚ÜóÔ∏è Merck (MRK): The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss. One will house its cancer drugs, including blockbuster Keytruda. Shares edged higher 1% on a strong day for health-care stocks.",
        "pubDate": "2026-02-23T18:50:31Z",
        "displayTime": "2026-02-23T18:50:31Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/cb781f9d-b9a5-3f5a-bfb4-b439b3b47382/stocks-to-watch-monday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/fdd47d79dd303dd8ed75edc6302549ad",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fE8MPZmAGd3rI2qE9tOdFg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/fdd47d79dd303dd8ed75edc6302549ad.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.05UnUkL1bcbBSdeL6wDDw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/fdd47d79dd303dd8ed75edc6302549ad.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-tariffs-02-23-2026/card/stocks-to-watch-monday-domino-s-pizza-dominion-energy-american-airlines-RT1RccoqGTzQdkbqaSL7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PSKY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "FBIN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T18:26:29+00:00",
    "headline": "Here's Why Shares of Arcellx Are Up Almost 80% Today",
    "summary": "Shares of biotech firm Arcellx are jumping on a down day for stocks.",
    "url": "https://www.investopedia.com/here-s-why-shares-of-arcellx-are-up-almost-80-today-aclx-stock-11912137",
    "source": "Investopedia",
    "provider": "yfinance",
    "raw": {
      "id": "4998ca08-b54b-329e-9bbf-7879425c17f9",
      "content": {
        "id": "4998ca08-b54b-329e-9bbf-7879425c17f9",
        "contentType": "STORY",
        "title": "Here's Why Shares of Arcellx Are Up Almost 80% Today",
        "description": "",
        "summary": "Shares of biotech firm Arcellx are jumping on a down day for stocks.",
        "pubDate": "2026-02-23T18:26:29Z",
        "displayTime": "2026-02-23T18:26:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/investopedia_245/e35be835065ca24c7b42a1e8367f3916",
          "originalWidth": 6000,
          "originalHeight": 4000,
          "caption": "Shares of Arcellx jumped Monday as stocks retreated broadly. Michael M. Santiago / Getty Images",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SCy6V2.z9Ct7cxCPwhiWtg--~B/aD00MDAwO3c9NjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/investopedia_245/e35be835065ca24c7b42a1e8367f3916.cf.webp",
              "width": 6000,
              "height": 4000,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dmhoqrfkcHGhg_LMF0cPoQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/investopedia_245/e35be835065ca24c7b42a1e8367f3916.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investopedia",
          "url": "https://www.investopedia.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investopedia.com/here-s-why-shares-of-arcellx-are-up-almost-80-today-aclx-stock-11912137",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-shares-arcellx-almost-182629000.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T21:51:26+00:00",
    "headline": "Dow Logs Worst Day in Nearly 5 Weeks Amid Renewed Tariffs Uncertainty; Tech Stocks Fall",
    "summary": "The Dow Jones Industrial Average posted its biggest one-day drop in nearly five weeks on Monday amid",
    "url": "https://finance.yahoo.com/news/dow-logs-worst-day-nearly-215126118.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "c5919be7-a169-3431-bf27-51008a8abeca",
      "content": {
        "id": "c5919be7-a169-3431-bf27-51008a8abeca",
        "contentType": "STORY",
        "title": "Dow Logs Worst Day in Nearly 5 Weeks Amid Renewed Tariffs Uncertainty; Tech Stocks Fall",
        "description": "",
        "summary": "The Dow Jones Industrial Average posted its biggest one-day drop in nearly five weeks on Monday amid",
        "pubDate": "2026-02-23T21:51:26Z",
        "displayTime": "2026-02-23T21:51:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "stock trading floor NYSE market wall street  - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IeAizqJZBy9vwDXxekAvFA--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OyOVBGCbqGk3V7zjfLwvvA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dow-logs-worst-day-nearly-215126118.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dow-logs-worst-day-nearly-215126118.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T21:05:00+00:00",
    "headline": "Gilead Sciences to Present at Upcoming Investor Conferences",
    "summary": "FOSTER CITY, Calif., February 23, 2026--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:",
    "url": "https://finance.yahoo.com/news/gilead-sciences-present-upcoming-investor-210500255.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "5e6f4fd7-d289-3f0b-9591-7e8cd16a4fd4",
      "content": {
        "id": "5e6f4fd7-d289-3f0b-9591-7e8cd16a4fd4",
        "contentType": "STORY",
        "title": "Gilead Sciences to Present at Upcoming Investor Conferences",
        "description": "",
        "summary": "FOSTER CITY, Calif., February 23, 2026--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:",
        "pubDate": "2026-02-23T21:05:00Z",
        "displayTime": "2026-02-23T21:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/195253fc616d378ae83053a236b81335",
          "originalWidth": 1728,
          "originalHeight": 576,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RhIMZrR_HFNYV66C.roTrg--~B/aD01NzY7dz0xNzI4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/195253fc616d378ae83053a236b81335.cf.webp",
              "width": 1728,
              "height": 576,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MMlnsP6dRIPTbLNcSodD9w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/195253fc616d378ae83053a236b81335.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-present-upcoming-investor-210500255.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-present-upcoming-investor-210500255.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T21:01:29+00:00",
    "headline": "Sector Update: Health Care Stocks Higher Late Afternoon",
    "summary": "Health care stocks rose late Monday afternoon, with the NYSE Health Care Index adding 0.6% and the S",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-higher-210129362.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "3d10cb86-fb30-36bd-b01e-8ad9d4fd8015",
      "content": {
        "id": "3d10cb86-fb30-36bd-b01e-8ad9d4fd8015",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Higher Late Afternoon",
        "description": "",
        "summary": "Health care stocks rose late Monday afternoon, with the NYSE Health Care Index adding 0.6% and the S",
        "pubDate": "2026-02-23T21:01:29Z",
        "displayTime": "2026-02-23T21:01:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-higher-210129362.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-higher-210129362.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IBRX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T21:01:00+00:00",
    "headline": "Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update",
    "summary": "Strategic reset positions Galapagos for long-term value creation Robust 2025 year-end cash and financial investments of ‚Ç¨3.0 billion and ongoing collaboration with Gilead enable flexibility to execute on a business development-led growth strategy 2026 year-end cash expected to be in the range of ‚Ç¨2.775 to ‚Ç¨2.850 billion, with reduced cell therapy one-time restructuring cash costs of ‚Ç¨25 million to an updated range of ‚Ç¨125 to ‚Ç¨175 million Management to host conference call tomorrow, February 24,",
    "url": "https://finance.yahoo.com/news/galapagos-reports-full-2025-financial-210100552.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "bcdbb364-35b2-306b-9577-a8160295f082",
      "content": {
        "id": "bcdbb364-35b2-306b-9577-a8160295f082",
        "contentType": "STORY",
        "title": "Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update",
        "description": "",
        "summary": "Strategic reset positions Galapagos for long-term value creation Robust 2025 year-end cash and financial investments of ‚Ç¨3.0 billion and ongoing collaboration with Gilead enable flexibility to execute on a business development-led growth strategy 2026 year-end cash expected to be in the range of ‚Ç¨2.775 to ‚Ç¨2.850 billion, with reduced cell therapy one-time restructuring cash costs of ‚Ç¨25 million to an updated range of ‚Ç¨125 to ‚Ç¨175 million Management to host conference call tomorrow, February 24,",
        "pubDate": "2026-02-23T21:01:00Z",
        "displayTime": "2026-02-23T21:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/27744832f947e91d201e1a07d1998d59",
          "originalWidth": 5097,
          "originalHeight": 938,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/i1RKzhbTOQ0vhJTc5774gg--~B/aD05Mzg7dz01MDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/27744832f947e91d201e1a07d1998d59.cf.webp",
              "width": 5097,
              "height": 938,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BuWmhr.OspHqtmIAsZ7b3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/27744832f947e91d201e1a07d1998d59.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/galapagos-reports-full-2025-financial-210100552.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/galapagos-reports-full-2025-financial-210100552.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GLPG"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]